T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.19% |
| 3 | Consumer Discretionary | 15.16% |
| 4 | Financials | 10.74% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Monte Rosa Therapeutics
GLUE
$1.35B
| $75M | 0.01% |
5,350,923
+1,204,004
| +29% | +$16.7M |
|
827
Choice Hotels
CHH
$4.71B
| $74.7M | 0.01% |
526,925
+34,117
| +7% | +$4.91M |
|
828
United Parks & Resorts
PRKS
$2.04B
| $74.2M | 0.01% |
996,425
-90,891
| -8% | -$5.96M |
|
829
Scholar Rock
SRRK
$6.46B
| $73.9M | 0.01% |
5,731,743
+469,142
| +9% | +$8.01M |
|
|
CFB
830
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $73.4M | 0.01% |
4,657,247
-25,681
| -0.5% | -$407K |
|
831
CRISPR Therapeutics
CRSP
$5.22B
| $73.2M | 0.01% |
1,166,114
+75,301
| +7% | +$4.73M |
|
832
Archer Daniels Midland
ADM
$38.6B
| $73M | 0.01% |
809,225
-39,105
| -5% | -$3.05M |
|
833
Tandem Diabetes Care
TNDM
$1.61B
| $73M | 0.01% |
627,697
+3,886
| +0.6% | +$454K |
|
834
Targa Resources
TRGP
$57.2B
| $73M | 0.01% |
966,755
-405,924
| -30% | -$25.6M |
|
|
TXNM
835
TXNM Energy Inc
TXNM
$5.91B
| $72.9M | 0.01% |
1,530,006
+939,067
| +159% | +$42.7M |
|
836
EXL Service
EXLS
$5.36B
| $72.7M | 0.01% |
2,536,510
-51,700
| -2% | -$1.32M |
|
837
Autodesk
ADSK
$54.5B
| $72.3M | 0.01% |
337,222
-20,463
| -6% | -$4.71M |
|
838
Maravai LifeSciences
MRVI
$861M
| $72.3M | 0.01% |
2,048,957
+102,221
| +5% | +$3.43M |
|
839
SPS Commerce
SPSC
$2.86B
| $72M | 0.01% |
548,831
-75,246
| -12% | -$9.42M |
|
840
Gentherm
THRM
$1.32B
| $71.8M | 0.01% |
982,766
-164,816
| -14% | -$13.7M |
|
841
Huron Consulting
HURN
$2.47B
| $71.5M | 0.01% |
1,560,664
+32,423
| +2% | +$1.5M |
|
|
SAGE
842
DELISTED
Sage Therapeutics
SAGE
| $71.4M | 0.01% |
2,158,504
+741,982
| +52% | +$27.9M |
|
843
Red Rock Resorts
RRR
$3.67B
| $71.1M | 0.01% |
1,464,403
+342,544
| +31% | +$16.3M |
|
844
Watsco Inc
WSO
$12.9B
| $70.9M | 0.01% |
232,810
-1,872
| -0.8% | -$534K |
|
845
Boston Omaha
BOC
$431M
| $70.6M | 0.01% |
2,781,339
-291
| -0% | -$7.93K |
|
|
PMT
846
PennyMac Mortgage Investment
PMT
$828M
| $70.1M | 0.01% |
4,149,083
-27,230
| -0.7% | -$456K |
|
847
Boyd Gaming
BYD
$6.05B
| $70M | 0.01% |
1,063,574
-95,804
| -8% | -$6.22M |
|
|
AZPN
848
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $69.9M | 0.01% |
422,478
-56,498
| -12% | -$9.34M |
|
849
Nexstar Media Group
NXST
$5.81B
| $69.5M | 0.01% |
368,641
+20,182
| +6% | +$3.51M |
|
850
Asana
ASAN
$2.28B
| $69.4M | 0.01% |
1,736,919
+1,701,649
| +4,825% | +$88.6M |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.